59 results
S-8
ODYY
Odyssey Health, Inc.
5 Jan 24
Registration of securities for employees
4:28pm
to the satisfaction of applicable regulatory authorities.
We may be substantially dependent on third parties to conduct our clinical trials.
We may
8-K
ODYY
Odyssey Health, Inc.
29 Dec 23
Completion of Acquisition or Disposition of Assets
9:00am
nasal delivery device.
The closing of the Odyssey Purchased Asset was subject to the satisfaction of customary closing conditions, which included: (1 … ; and (6) Oragenics completion of its due diligence of the Purchased Assets to its satisfaction.
Item 9.01
Financial Statements and Exhibits
(d
8-K
EX-99.1
agr9h0s pf
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
n540arnbhef65
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-2.1
h2iixhh 96i7uclr
5 Oct 23
Oragenics to Acquire Odyssey Health’s Neurological Drug Technology Pipeline Including Concussion Drug Candidate
6:30am
8-K
EX-10.1
sv8re8fa
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.3
92hlsnczg vzoj
18 Aug 23
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-10.1
kaxu op8g2f
23 Nov 22
Entry into a Material Definitive Agreement
5:10pm